amiloride has been researched along with amantadine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gage, PW; Horan, CR; Premkumar, A | 1 |
| Chou, D; Eldstrom, J; Fedida, D; Jalily, PH; Kwan, DC; Miller, SC; Niikura, M; Tai, SS; Tietjen, I | 1 |
| Dregni, AJ; Hong, M; Kolocouris, A; Mandala, VS; McKay, MJ; Shcherbakov, AA | 1 |
| B Andreas, L; Becker, S; Bentzen, BH; Giller, K; Jeppesen, MG; Kledal, TN; Kolocouris, A; Mujezinovic, A; Rosenkilde, MM; Toft-Bertelsen, TL; Tzortzini, E; Xue, K | 1 |
2 review(s) available for amiloride and amantadine
| Article | Year |
|---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for amiloride and amantadine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Dengue virus M protein C-terminal peptide (DVM-C) forms ion channels.
Topics: Amantadine; Amiloride; Antineoplastic Agents; Antiviral Agents; Dengue Virus; Ion Channels; Membranes, Artificial; Peptides; Viral Matrix Proteins | 2005 |
Mechanisms of Action of Novel Influenza A/M2 Viroporin Inhibitors Derived from Hexamethylene Amiloride.
Topics: Amantadine; Amiloride; Animals; Antiviral Agents; Cell Death; Cell Line; Guanidines; Humans; Hydrogen-Ion Concentration; Influenza A virus; Influenza A Virus, H9N2 Subtype; Ion Channel Gating; Mice; Molecular Docking Simulation; Patch-Clamp Techniques; Viral Matrix Proteins | 2016 |
Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers.
Topics: Amantadine; Amiloride; Antiviral Agents; Coronavirus Envelope Proteins; Dimyristoylphosphatidylcholine; Hydrogen-Ion Concentration; Lipid Bilayers; Magnetic Resonance Spectroscopy; Models, Molecular; Phenylalanine; Phospholipids; Protein Conformation; Protein Domains; SARS-CoV-2 | 2020 |
Amantadine has potential for the treatment of COVID-19 because it inhibits known and novel ion channels encoded by SARS-CoV-2.
Topics: Amantadine; Amiloride; Antiviral Agents; Ion Channels; Rimantadine; SARS-CoV-2; Viral Proteins | 2021 |